|
|
|
|
|
|
|
|
|
Author |
Message |
|
|
Sat Jan 22, 2011 4:18 am |
I have the opposite experience, and my skin is fairly tough. I've stopped using the ADC 0.1% because I find it too strong for me. I've gone back to the 0.05%.
The bottom line is that this is a prescription drug - the active ingredient should be the same strength, no matter what the brand is. |
_________________ Born 1950. There's a new cream on the market that gets rid of wrinkles - you smear it on the mirror!! |
|
|
|
Sat Jan 22, 2011 9:00 pm |
I started my retinA journey with the obagi 0.1 cream one.then purchased the 0.1 retinA cream from ADC. I didn't see any difference between the two. |
|
|
|
|
Sun Jan 23, 2011 9:58 am |
Here are my 2 cents...
... the "peeling effect" does not really mean that the Retin-A is working nor is it a particularly desirable effect.
Basically, RetinA works in 2 levels: epidermis and dermis
In the epidermis, it causes increase of cell turnover, decrease of melanin, and it disrupts the epidermal barrier
In the dermis, it increases collagen among other things.
Research has shown that there is no increase of effect after 0.05. So if you use 0.1 you're basically just increasing the irritation due to barrier disruption, and decreased thickness of epidermis, not increasing the beneficial effects.
So personally, unless I had horrible acne that needed a lot of barrier disruption for extra peeling,and extra thin epidermis, I don't think I would do it.
All the best! |
|
|
|
Fri Feb 07, 2025 6:44 pm |
If this is your first visit to the EDS Forums please take the time to register. Registration is required for you to post on the forums. Registration will also give you the ability to track messages of interest, send private messages to other users, participate in Gift Certificates draws and enjoy automatic discounts for shopping at our online store. Registration is free and takes just a few seconds to complete.
Click Here to join our community.
If you are already a registered member on the forums, please login to gain full access to the site. |
|
|
|
|
|